Related Experiment Video
Updated: Aug 15, 2026

10:33
Assessment of Right Ventricular Structure and Function in Mouse Model of Pulmonary Artery Constriction by Transthoracic Echocardiography
Published on: February 3, 2014
Practical use of T wave morphology assessment
1Division of Cardiology, Benjamin Franklin Hospital, Free University of Berlin, Berlin, Germany. mzabel@compuserve.com
Summary
Novel electrocardiogram (ECG) markers assessing T wave morphology show promise for predicting sudden cardiac death risk. These new ECG variables effectively identify patients who may benefit from an implantable cardioverter-defibrillator (ICD).
Area of Science:
- Cardiology
- Biomedical Engineering
- Computational Medicine
Background:
- Traditional QT dispersion (QTd) from 12-lead ECG has limitations in predicting sudden cardiac death risk.
- Novel ECG variables analyzing T wave morphology offer potential improvements over QTd.
Purpose of the Study:
- To evaluate novel ECG variables of T wave morphology for risk stratification in cardiovascular disease patients.
- To determine if these new ECG markers can identify patients at risk for sudden cardiac death.
Main Methods:
- Two clinical studies assessed post-myocardial infarction (MI) patients and US veterans with cardiovascular disease.
- Evaluated variables included total cosine R-to-T (TCRT), T wave morphology dispersion, T wave loop dispersion, and T wave residua.
- Data analyzed using Cox regression, considering factors like age, left ventricular hypertrophy (LVH), and left ventricular ejection fraction (LVEF).
Main Results:
- In post-MI patients, TCRT and T wave loop dispersion independently predicted mortality.
- In US veterans, absolute and relative T wave residua independently predicted long-term risk.
- Novel ECG parameters demonstrated effectiveness in risk stratification for cardiovascular disease.
Conclusions:
- Novel ECG variables derived from T wave morphology offer a promising tool for risk stratification in cardiovascular disease.
- These easily accessible ECG markers may help identify patients who could benefit from an implantable cardioverter-defibrillator (ICD).
- Further research may validate these markers for clinical use in preventing sudden cardiac death.

